Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours

Figure 3

Loss of syndecan-4 staining in aggressive NSGCTs. Tumour cell associated staining and variable stromal staining for syndecan-4 in stage I teratoma/seminoma (a) and stage I embryonal/seminoma (b). Variable stromal staining and loss of tumour cell associated immunoreactivity for syndecan-4 in stage II embryonal/yolk sac (c) and embryonal stage III tumours (d). Scale bar denotes 50 μm.